Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Artificial Intelligence-Driven Computational Approaches in the Development of Anticancer Drugs.
Disparate outcomes in nonsmall cell lung cancer by immigration status.
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306.
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Artificial Intelligence-Driven Computational Approaches in the Development of Anticancer Drugs.
Artificial Intelligence-Driven Computational Approaches in the Development of Anticancer Drugs. Cancers (Basel). 2024 Nov 20; 16(22).
View in:
PubMed
authors with profiles
Ravi Salgia